Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2

por Karathedath, Sreeja, Rajamani, Bharathi M., Musheer Aalam, Syed Mohammed, Abraham, Ajay, Varatharajan, Savitha, Krishnamurthy, Partha, Mathews, Vikram, Velayudhan, Shaji Ramachandran, Balasubramanian, Poonkuzhali
Publicado 2017

Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo

por Rajamani, Bharathi M., Illangeswaran, Raveen Stephen Stallon, Benjamin, Esther Sathya Bama, Balakrishnan, Balaji, Jebanesan, Daniel Zechariah Paul, Das, Saswati, Pai, Aswin Anand, Vidhyadharan, Rakhi Thalayattu, Mohan, Ajith, Karathedath, Sreeja, Abraham, Aby, Mathews, Vikram, Velayudhan, Shaji R., Balasubramanian, Poonkuzhali
Publicado 2023

Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients

por Rajamani, Bharathi M., Benjamin, Esther Sathya Bama, Abraham, Aby, Ganesan, Sukanya, Lakshmi, Kavitha M., Anandan, Senthamizhselvi, Karathedath, Sreeja, Varatharajan, Savitha, Mohanan, Ezhilpavai, Janet, Nancy Beryl, Srivastava, Vivi M., Ramachandran Velayudhan, Shaji, Kulkarni, Uday P., Devasia, Anup J., Fouzia, N. A., Korula, Anu, George, Biju, Srivastava, Alok, Mathews, Vikram, Balasubramanian, Poonkuzhali
Publicado 2020